Clinical Trial: Injectable Platelet Rich Fibrin Versus Platelet Rich Plasma Injection in Degenerative Temporomandibular Joint

U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07078006) titled 'Injectable Platelet Rich Fibrin Versus Platelet Rich Plasma Injection in Degenerative Temporomandibular Joint' on Dec. 31, 2024.

Brief Summary: The study aimed to compare the efficacy of injectable platelet rich fibrin (I-PRF) versus platelet rich plasma (PRP) injection in degenerative temporomandibular joint (TMJ).

Study Start Date: Feb. 22, 2023

Study Type: INTERVENTIONAL

Condition: Platelet Rich Fibrin Platelet Rich Plasma Injection Degenerative Temporomandibular Joint

Intervention: OTHER: Platelet Rich Fibrin

Patients underwent arthrocentesis followed by a platelet-rich fibrin (PRF) injection using a conventional temporom...